Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Hypoglycemia is a cause of significant morbidity among patients with diabetes and may be associated with greater risk of death. We conducted a retrospective study to determine whether patient self-report of severe hypoglycemia is associated with increased mortality. RESEARCH DESIGN AND METHODS: Adult patients (N = 1,020) seen in a specialty diabetes clinic between August 2005 and July 2006 were questioned about frequency of hypoglycemia during a preencounter interview; 7 were lost to follow-up and excluded from analysis. Mild hypoglycemia was defined as symptoms managed without assistance, and severe hypoglycemia was defined as symptoms requiring external assistance. Mortality data, demographics, clinical characteristics, and Charlson comorbidity index (CCI) were obtained from the electronic medical record after 5 years. Patients were stratified by self-report of hypoglycemia at baseline, demographics were compared using the two-sample t test, and risk of death was expressed as odds ratio (95% CI). Associations were controlled for age, sex, diabetes type and duration, CCI, HbA1c, and report of severe hypoglycemia. RESULTS: In total, 1,013 patients with type 1 (21.3%) and type 2 (78.7%) diabetes were questioned about hypoglycemia. Among these, 625 (61.7%) reported any hypoglycemia, and 76 (7.5%) reported severe hypoglycemia. After 5 years, patients who reported severe hypoglycemia had 3.4-fold higher mortality (95% CI 1.5–7.4; P = 0.005) compared with those who reported mild/no hypoglycemia. CONCLUSIONS: Self-report of severe hypoglycemia is associated with 3.4-fold increased risk of death. Patient-reported outcomes, including patient-reported hypoglycemia, may therefore augment risk stratification and disease management of patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The primary cause of hypoglycemia is intensification of antihyperglycemic therapy (almost always using SUs [or to a lesser extent glinides] and/or insulin) aimed at achieving lower A1C targets, as demonstrated by intensive therapy trials.1202,1203”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1202]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [195]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An association between selfreported level 3 hypoglycemia and 5-year mortality has also been reported in clinical practice (91).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [91]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587 · cited 1×
“The CCI is an extensively studied and widely used measure that weighs comorbid conditions by the strength of their association with 1-year mortality (17,18); it has been previously validated for use in diabetes (19).”
BackgroundIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“An association of self-reported severe hypoglycemia with 5-year mortality has also been reported in clinical practice (294).”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“An association of self-reported severe hypoglycemia with 5-year mortality has also been reported in clinical practice (228).”
Background6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
“An association between self-reported level 3 hypoglycemia and 5-year mortality has also been reported in clinical practice (93).”
Background6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
“tween self-reported level 3 hypoglycemia and 5-year mortality has also been reported in clinical practice (80).”
Background6. Glycemic Targets: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s006 · Cited by 762
6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744
“reported in clinical practice (68) Young children with type 1 diabetes and the elderly, including those with type 1 and type 2 diabetes (61,69), are noted as particularly vulnerable to”
Background6. Glycemic Targets: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s006 · Cited by 684
6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s006 · Cited by 655
“mia and 5-year mortality has also been reported in clinical practice (52) Young children with type 1 diabetes and the elderly, including those with”
BackgroundHering, B. J., Clarke, W. R., Bridges, N. D., Eggerman, T. L., Alejandro, R., Bellin, M. D., Chaloner, K., Czarniecki, C. W., Goldstein, J. S., Hunsicker, L. G., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1988 · Cited by 645
“Severe hypoglycemia is a debilitating, life-threatening complication of T1D (1,2,6,29) that, in some patients, is refractory to medical treatment (7,8,10).”
BackgroundHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 486
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Goto, A., Arah, O. A., Goto, M., Terauchi, Y., & Noda, M. (2013) · BMJ · doi:10.1136/bmj.f4533 · Cited by 492
Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature review
Lau, L., Lew, J., Borschmann, K., Thijs, V., & Ekinci, E. I. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.12932 · Cited by 443
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Self-citationPotential overtreatment of diabetes mellitus in older adults with tight glycemic control
Lipska, K. J., Ross, J. S., Miao, Y., Shah, N. D., Lee, S. J., & Steinman, M. A. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7345 · Cited by 408
Self-citationHäring, H.-U., Merker, L., Seewaldt-Becker, E., Weimer, M., Meinicke, T., Broedl, U. C., Woerle, H. J., & on behalf of the EMPA-REG MET Trial Investigators (2014) · Diabetes Care · doi:10.2337/dc13-2105 · Cited by 400
Lipska, K. J., Ross, J. S., Wang, Y., Inzucchi, S. E., Minges, K., Karter, A. J., Huang, E. S., Desai, M. M., Gill, T. M., & Krumholz, H. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1824 · Cited by 391
Kovacs, C. S., Seshiah, V., Swallow, R., Jones, R., Rattunde, H., Woerle, H. J., Broedl, U. C., & on behalf of the EMPA‐REG PIO™ trial investigators (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12188 · Cited by 387
“particularly in elderly patients [16] and is associated with decreased treatment satisfaction and health-related quality of life [28,29] as well as increased mortality rates [30].”
BackgroundKhunti, K., Davies, M., Majeed, A., Thorsted, B. L., Wolden, M. L., & Paul, S. K. (2015) · Diabetes Care · doi:10.2337/dc14-0920 · Cited by 356
“been proposed as a surrogate measure of greater disease burden and thus an indirect marker of CV risk (32).”
BackgroundBergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307
Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013
Lipska, K. J., Yao, X., Herrin, J., McCoy, R. G., Ross, J. S., Steinman, M. A., Inzucchi, S. E., Gill, T. M., Krumholz, H. M., & Shah, N. D. (2017) · Diabetes Care · doi:10.2337/dc16-0985 · Cited by 306
Self-citationArnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s009 · Cited by 271
HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes
Lipska, K. J., Warton, E. M., Huang, E. S., Moffet, H. H., Inzucchi, S. E., Krumholz, H. M., & Karter, A. J. (2013) · Diabetes Care · doi:10.2337/dc13-0610 · Cited by 246
“[15,16], and increased mortality [17]).”
Reddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245
Chou, D. H.-C., Webber, M. J., Tang, B. C., Lin, A. B., Thapa, L. S., Deng, D., Truong, J. V., Cortinas, A. B., Langer, R., & Anderson, D. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424684112 · Cited by 234
“Acute hypoglycemic episodes can result in coma or death (7).”
BackgroundGlycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia
Cryer, P. E. (2014) · Diabetes · doi:10.2337/db14-0059 · Cited by 236
Choudhary, P., Rickels, M. R., Senior, P. A., Vantyghem, M.-C., Maffi, P., Kay, T. W., Keymeulen, B., Inagaki, N., Saudek, F., Lehmann, R., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0090 · Cited by 233
Silbert, R., Salcido-Montenegro, A., Rodriguez-Gutierrez, R., Katabi, A., & McCoy, R. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1018-0 · Cited by 229
Self-citationLee, A. K., Warren, B., Lee, C. J., McEvoy, J. W., Matsushita, K., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetes Care · doi:10.2337/dc17-1669 · Cited by 226
“Our analysis of cause-specific mortality extends the literature on this topic (4,6,31,32).”
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s008 · Cited by 215
“been reported in clinical practice (60).”
Glycemic Monitoring and Management in Advanced Chronic Kidney Disease
Galindo, R. J., Beck, R. W., Scioscia, M. F., Umpierrez, G. E., & Tuttle, K. R. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa017 · Cited by 202
Lane, W., Bailey, T. S., Gerety, G., Gumprecht, J., Philis-Tsimikas, A., Hansen, C. T., Nielsen, T. S. S., Warren, M., Group Information, & 1, T. S. (2017) · JAMA · doi:10.1001/jama.2017.7115 · Cited by 206
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s009 · Cited by 205
“poglycemia and 5-year mortality has also been reported in clinical practice (54).”
BackgroundMarfil-Garza, B. A., Imes, S., Verhoeff, K., Hefler, J., Lam, A., Dajani, K., Anderson, B., O'Gorman, D., Kin, T., Bigam, D., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00114-0 · Cited by 205
Advances in β-cell replacement therapy for the treatment of type 1 diabetes
Vantyghem, M.-C., de Koning, E. J. P., Pattou, F., & Rickels, M. R. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31334-0 · Cited by 201
Glucose-Responsive Nanoparticles for Rapid and Extended Self-Regulated Insulin Delivery
Volpatti, L. R., Matranga, M. A., Cortinas, A. B., Delcassian, D., Daniel, K. B., Langer, R., & Anderson, D. G. (2020) · ACS Nano · doi:10.1021/acsnano.9b06395 · Cited by 189
Digital diabetes: Perspectives for diabetes prevention, management and research
Fagherazzi, G., & Ravaud, P. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.08.012 · Cited by 188
Wright, L. A.-C., & Hirsch, I. B. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0029 · Cited by 178
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Madhu, S., Chawla, R., Makkar, B., Ghosh, S., Saboo, B., & Kalra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_225_20 · Cited by 167
“[184] TZDs have demonstrated beneficial effects in attenuating dyslipidaemia commonly observed in patients with chronic T2DM.”
ResultInfluentialStahn, A., Pistrosch, F., Ganz, X., Teige, M., Koehler, C., Bornstein, S., & Hanefeld, M. (2014) · Diabetes Care · doi:10.2337/dc13-0600 · Cited by 173
“4 in a recently published retrospective observational study after adjustment for major risk factors and Charlson comorbidity index (7).”
Background6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
Self-citationpH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery
Zhang, C., Hong, S., Liu, M.-D., Yu, W.-Y., Zhang, M.-K., Zhang, L., Zeng, X., & Zhang, X.-Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.038 · Cited by 165
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700234 · Cited by 166
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers
Podust, V. N., Balan, S., Sim, B.-C., Coyle, M. P., Ernst, U., Peters, R. T., & Schellenberger, V. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.038 · Cited by 166
“Hypoglycemia is the most common complicationof diabetes therapy, affecting 90% of the diabetic population [78 – 80], with patients who experience severe hypoglycemia having an increased mortality risk in comparison to those not experiencing severe hypoglycemia [81 – 84].”
Woldaregay, A. Z., Årsand, E., Botsis, T., Albers, D., Mamykina, L., & Hartvigsen, G. (2019) · Journal of Medical Internet Research · doi:10.2196/11030 · Cited by 165
“Moreover, studies suggest a hypoglycemia episode could result in a higher hospitalization and mortality rate [5].”
BackgroundSevere Hypoglycemia Predicts Mortality in Diabetes
Cryer, P. E. (2012) · Diabetes Care · doi:10.2337/dc12-0749 · Cited by 158
Benefits and harms of intensive glycemic control in patients with type 2 diabetes
Rodriguez-Gutierrez, R., Gonzalez-Gonzalez, J. G., Zuñiga-Hernandez, J. A., & McCoy, R. G. (2019) · BMJ · doi:10.1136/bmj.l5887 · Cited by 152
Self-citationKarter, A. J., Warton, E. M., Lipska, K. J., Ralston, J. D., Moffet, H. H., Jackson, G. G., Huang, E. S., & Miller, D. R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3844 · Cited by 150
Preventing undesirable behavior of intelligent machines
Thomas, P. S., Castro da Silva, B., Barto, A. G., Giguere, S., Brun, Y., & Brunskill, E. (2019) · Science · doi:10.1126/science.aag3311 · Cited by 142
McCoy, R. G., Lipska, K. J., Van Houten, H. K., & Shah, N. D. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.19099 · Cited by 141
Self-citationMcCall, A. L., Lieb, D. C., Gianchandani, R., MacMaster, H., Maynard, G. A., Murad, M. H., Seaquist, E., Wolfsdorf, J. I., Wright, R. F., & Wiercioch, W. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac596 · Cited by 123
Freeman, R. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00006-0 · Cited by 162
Cariou, B., Fontaine, P., Eschwege, E., Lièvre, M., Gouet, D., Huet, D., Madani, S., Lavigne, S., & Charbonnel, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.10.007 · Cited by 129
RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017
Bajaj, S. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0604-7 · Cited by 125
Rickels, M. R., Ruedy, K. J., Foster, N. C., Piché, C. A., Dulude, H., Sherr, J. L., Tamborlane, W. V., Bethin, K. E., DiMeglio, L. A., Wadwa, R. P., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1498 · Cited by 128
“Such severe hypoglycemia, which is not uncommon, can be associated with significant morbidity (5) and mortality (6).”
BackgroundLim, S. K., Kang, S. M., Kim, K. M., Moon, J. H., Choi, S. H., Hwang, H. Y., Jung, H. S., Park, K. S., Ryu, J. O., & Jang, H. C. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0754-8 · Cited by 143
“dangerous factors contributing to high mortality in patients with diabetes by increasing cardiovascular events or neurologic deficits, particularly in older patients [21, 22].”
BackgroundContinuous Glucose Monitoring: A Brief Review for Primary Care Practitioners
Ajjan, R., Slattery, D., & Wright, E. (2019) · Advances in Therapy · doi:10.1007/s12325-019-0870-x · Cited by 120
Hypoglycemia in Patients with Diabetes and Renal Disease
Alsahli, M., & Gerich, J. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050948 · Cited by 123
“Moreover, hypoglycemia is associated with significant morbidity and mortality [2–6].”
BackgroundHypoglycemia and Cardiovascular Risk: Is There a Major Link?
Hanefeld, M., Frier, B. M., & Pistrosch, F. (2016) · Diabetes Care · doi:10.2337/dcs15-3014 · Cited by 121
Lablanche, S., Borot, S., Wojtusciszyn, A., Bayle, F., Tétaz, R., Badet, L., Thivolet, C., Morelon, E., Frimat, L., Penfornis, A., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0094 · Cited by 122
“2 increased risk of death (31,32) and that glucose variability is associated with a higher risk of microangiopathy progression (33).”
BackgroundRama Chandran, S., Tay, W. L., Lye, W. K., Lim, L. L., Ratnasingam, J., Tan, A. T. B., & S.L. Gardner, D. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0388 · Cited by 114
“17 A post hoc analysis of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study showed that the risk of severe hypoglycemia was higher among those with poor glycemic control.”
Kautzky‐Willer, A., Kosi, L., Lin, J., & Mihaljevic, R. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12449 · Cited by 112
Tramadol Use and the Risk of Hospitalization for Hypoglycemia in Patients With Noncancer Pain
Fournier, J., Azoulay, L., Yin, H., Montastruc, J., & Suissa, S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6512 · Cited by 112
Sherr, J. L., Laffel, L. M., Liu, J., Wolf, W., Bispham, J., Chapman, K. S., Finan, D., Titievsky, L., Liu, T., Hagan, K., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1765 · Cited by 99
Ou, S.-M., Shih, C.-J., Chao, P.-W., Chu, H., Kuo, S.-C., Lee, Y.-J., Wang, S.-J., Yang, C.-Y., Lin, C.-C., Chen, T.-J., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0308 · Cited by 101
Smart approaches to glucose-responsive drug delivery
Webber, M. J., & Anderson, D. G. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1055749 · Cited by 110
“Acute hypoglycemic episodes can result in coma or death [11].”
BackgroundMorales, J., & Schneider, D. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.004 · Cited by 128
New advances in type 1 diabetes
Subramanian, S., Khan, F., & Hirsch, I. B. (2024) · BMJ · doi:10.1136/bmj-2023-075681 · Cited by 88
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
Ajjan, R. A. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0021 · Cited by 97
Pedersen‐Bjergaard, U., Kristensen, P. L., Beck‐Nielsen, H., Nørgaard, K., Perrild, H., Christiansen, J. S., Jensen, T. J., Hougaard, P., Parving, H., Thorsteinsson, B., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70073-7 · Cited by 103
Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., Cherney, D. Z. I., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155931 · Cited by 103
Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review
Hanefeld, M., Duetting, E., & Bramlage, P. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-135 · Cited by 93
“The effects of hypoglycaemia are poorly established and sometimes overlooked, but can have potentially lifethreatening consequences [18].”
BackgroundReddy, M., Jugnee, N., Anantharaja, S., & Oliver, N. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0252 · Cited by 91
A Concise and Systematic Review on Non-Invasive Glucose Monitoring for Potential Diabetes Management
Laha, S., Rajput, A., Laha, S. S., & Jadhav, R. (2022) · Biosensors · doi:10.3390/bios12110965 · Cited by 99
“These adverse health events include cardiovascular ischemia [4], dementia [5], falls [6], and even deaths [7].”
BackgroundManagement of diabetes in older adults
Sesti, G., Antonelli Incalzi, R., Bonora, E., Consoli, A., Giaccari, A., Maggi, S., Paolisso, G., Purrello, F., Vendemiale, G., & Ferrara, N. (2018) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.11.007 · Cited by 84
Yun, J., Park, Y., Han, K., Cha, S., Ahn, Y., & Ko, S. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0909-y · Cited by 99
D’Amato, C., Morganti, R., Greco, C., Di Gennaro, F., Cacciotti, L., Longo, S., Mataluni, G., Lauro, D., Marfia, G. A., & Spallone, V. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116653240 · Cited by 83
Management of Type 1 Diabetes in Older Adults
Dhaliwal, R., & Weinstock, R. S. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.1.9 · Cited by 80
Lin, Y. K., Fisher, S. J., & Pop‐Busui, R. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13290 · Cited by 82
Lin, Y. K., Hung, M., Sharma, A., Chan, O., Varner, M. W., Staskus, G., & Fisher, S. J. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0527 · Cited by 81
Is insulin pump therapy effective in Type 1 diabetes?
Pickup, J. C. (2019) · Diabetic Medicine · doi:10.1111/dme.13793 · Cited by 77
McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A. (2013) · Endocrine Practice · doi:10.4158/ep12382.or · Cited by 76
Self-citationHypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.07.013 · Cited by 90
Pistrosch, F., Ganz, X., Bornstein, S. R., Birkenfeld, A. L., Henkel, E., & Hanefeld, M. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0727-y · Cited by 74
“However, it still remains to be clarified whether there is a direct pathophysiological link or whether hypoglycemia is only a marker of vulnerability to these events [1–5].”
BackgroundBest Practice for Diabetic Patients on Hemodialysis 2012
Nakao, T., Inaba, M., Abe, M., Kaizu, K., Shima, K., Babazono, T., Tomo, T., Hirakata, H., Akizawa, T., & Japanese Society for Dialysis Therapy (2015) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12299 · Cited by 80
“Considering recent reports (7,8), the prevention of hypoglycemia is also important.”
BackgroundGlucose-responsive insulin release: Analysis of mechanisms, formulations, and evaluation criteria
Yang, J., & Cao, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.043 · Cited by 74
“Particularly, hypoglycemia resulting from an extra dosage of insulin can induce unconsciousness, brain damage and even death [14].”
The risks of nocturnal hypoglycaemia in insulin-treated diabetes
Graveling, A. J., & Frier, B. M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.012 · Cited by 85
Rickels, M. R. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14214 · Cited by 71
Mattishent, K., & Loke, Y. K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.571568 · Cited by 69
“(32) Retrospective cohort 1013 Diabetes Clinic, single centre, US August 2005–July 2006 Medical records Type 1 and Type 2 diabetes, mean age 60.”
BackgroundExercise‐induced hypoglycaemia in type 1 diabetes
Cockcroft, E., Narendran, P., & Andrews, R. C. (2020) · Experimental Physiology · doi:10.1113/ep088219 · Cited by 80
Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 Diabetes
Rickels, M. R., Fuller, C., Dalton-Bakes, C., Markmann, E., Palanjian, M., Cullison, K., Tiao, J., Kapoor, S., Liu, C., Naji, A., et al. (2015) · Diabetes · doi:10.2337/db14-1620 · Cited by 67
“Hypoglycemia unawareness in T1D is associated with a 20-fold increased risk for experiencing severe hypoglycemia (3), which itself contributes importantly to increased morbidity (4) and mortality (5).”
Lu, C.-L., Shen, H.-N., Hu, S. C., Wang, J.-D., & Li, C.-Y. (2016) · Diabetes Care · doi:10.2337/dc15-2418 · Cited by 66
“Although patients with T1DM may suffer more frequently from hypoglycemia than those with T2DM (8), very few studies have investigated whether hypoglycemia may also increase the risk of CVD (6,9,10) or death (1,6,7) in patients with T1DM; moreover, the results of these studies have been inconclusive (6,9,10) because of…”
ResultGilsanz, P., Karter, A. J., Beeri, M. S., Quesenberry, C. P., & Whitmer, R. A. (2017) · Diabetes Care · doi:10.2337/dc17-1566 · Cited by 66
“Severe hyper- and hypoglycemic events are common among people with T1D and increase the risk of neurologic damage (34), coma (6), dementia (31), and mortality (6,8).”
BackgroundHypoglycemia Associated With Hospitalization and Adverse Events in Older People
Majumdar, S. R., Hemmelgarn, B. R., Lin, M., McBrien, K., Manns, B. J., & Tonelli, M. (2013) · Diabetes Care · doi:10.2337/dc13-0523 · Cited by 65
“Cardiovascular disease 75 (17) 7,854 (9) ,0.”
Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Beckman, J. A., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108101 · Cited by 64
“133,134 Fear of hypoglycemia complications poses a significant barrier to glycemic control in T2D and contributes to under-treatment of the disease.”
McCoy, R. G., Van Houten, H. K., Ross, J. S., Montori, V. M., & Shah, N. D. (2015) · BMJ · doi:10.1136/bmj.h6138 · Cited by 60
Self-citation
Metadata
- Authors
- McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A.
- Affiliations
- Mayo Clinic (US)
- Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
- Corresponding author
- Smith, Steven A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-08-14
- Volume
- 35
- Issue
- 9
- Pages
- 1897-1901
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3425008
- OpenAlex
- W2153957843
- Semantic Scholar
- 28fffca9598fb24277bf9ea60849e4ad6060f499
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 34 · 2023: 37 · 2022: 46 · 2021: 35 · 2020: 46 · 2019: 59 · 2018: 36 · 2017: 43 · 2016: 50 · 2015: 49 · 2014: 39 · 2013: 24 · 2012: 3
- FWCI
- 29.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, diabetes mortality, patient self-report, patient-reported outcomes, type 1 diabetes, type 2 diabetes, risk stratification, Charlson Comorbidity Index, HbA1c, diabetes complications
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Male, Retrospective Studies, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.